Hydroxytyrosol derivatives, their method of preparation and use in personal care

US9334229B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9334229-B2
Application numberUS-201314070746-A
CountryUS
Kind codeB2
Filing dateNov 4, 2013
Priority dateNov 4, 2013
Publication dateMay 10, 2016
Grant dateMay 10, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Hydroxytyrosol derivative compositions, methods for their manufacture, and their use in personal care products are disclosed. Lipophilic hydroxytyrosol carbonate ester compound can be made by oxidizing a substituted hydroxybenzaldehyde compound with an oxidizing agent such as hydrogen peroxide under mild conditions. The process involves enzymatic esterification of 4-(2-hydroxyethyl)phenol to form the corresponding ester, the introduction of a formyl group ortho to the phenolic hydroxyl group of the ester to form a lipophilic formyltyrosol ester; oxidation of the lipophilic formyltyrosol ester with a peroxide compound to form a lipophilic hydroxytyrosol ester compound; and reaction of lipophilic hydroxytyrosol ester compound with carbonic acid ester derivatives to form a lipophilic hydroxytyrosol carbonic ester compound. These compounds are useful is a wide variety of personal care compositions as anti-aging compounds that are stable against oxidation.

First claim

Opening claim text (preview).

What we claim is: 1. A lipophilic hydroxytyrosol carbonate ester compound having a structure represented by the general Formula 2: wherein R 1 is a saturated or unsaturated, branched or straight chain, substituted or unsubstituted, aliphatic, alicyclic, or alkaryl C 1 -C 22 aliphatic, alicyclic, or alkaryl group; and wherein R 2 is a saturated or unsaturated, branched or straight chain, substituted or unsubstituted C 2 -C 24 aliphatic, alicyclic, or alkaryl group. 2. The compound of claim 1 , wherein R 2 is a C 8 -C 24 group. 3. The compound of claim 2 , wherein R 2 is a C 10 -C 24 group. 4. The compound of claim 3 , wherein R 2 is a C 12 -C 24 group. 5. The compound of claim 4 , wherein R 2 has at least 6 more carbon atoms than the R 1 group. 6. The compound of claim 4 , wherein R 2 has at least 10 more carbon atoms than the R 1 group. 7. The compound of claim 1 , wherein R 1 is substituted with one to three groups selected from C 1 -C 6 -alkoxy, carboxyl, C 1 -C 15 aminocarbonyl, C 1 -C 15 amido, cyano, C 2 -C 15 -alkoxycarbonyl, C 2 -C 15 -alkoxycarbonyloxy, C 2 -C 15 alkanoyloxy, hydroxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, thiol, thioether, and halogen. 8. The compound of any one of claims 1 - 7 , wherein R 2 is an aliphatic group. 9. The compound of any one of claims 1 - 7 , wherein R 2 is un-substituted. 10. The compound of any one of claims 1 - 7 , wherein R 2 ═C 12 -C 24 and R 1 ═C 1 -C 6 . 11. A composition for topical application to a keratinous surface, said composition comprising a lipophilic hydroxytyrosol carbonate ester compound of the general Formula 2: wherein R 1 is a saturated or unsaturated, branched or straight chain, substituted or unsubstituted, aliphatic, alicyclic, or alkaryl C 1 -C 22 aliphatic, alicyclic, or alkaryl group; and wherein R 2 is a saturated or unsaturated, branched or straight chain, substituted or un-substituted C 2 -C 24 aliphatic, alicyclic, or alkaryl group. 12. The composition of claim 11 , wherein said composition comprises a cosmetic composition. 13. The composition of claim 12 , wherein said composition comprises an eyeliner, eyeshadow, lipstick, mascara, foundation, blush, or nail polish. 14. The composition of claim 11 , wherein said composition comprises a skin care composition. 15. The composition of claim 14 , wherein said composition comprises a skin moisturizer, anti-aging lotion, infant care product, body oil, after-bath and shower product, soap, shampoo, or sun screen or sun tan lotion.

Assignees

Inventors

Classifications

  • esterified with trihydroxylic compounds (fats, oils C11B, C11C) · CPC title

  • by isomerisation; by change of size of the carbon skeleton · CPC title

  • esterified with dihydroxylic compounds · CPC title

  • C07C69/96Primary

    Esters of carbonic or haloformic acids · CPC title

  • Esters of keto-carboxylic acids {or aldehydo-carboxylic acids} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9334229B2 cover?
Hydroxytyrosol derivative compositions, methods for their manufacture, and their use in personal care products are disclosed. Lipophilic hydroxytyrosol carbonate ester compound can be made by oxidizing a substituted hydroxybenzaldehyde compound with an oxidizing agent such as hydrogen peroxide under mild conditions. The process involves enzymatic esterification of 4-(2-hydroxyethyl)phenol to fo…
Who is the assignee on this patent?
Eastman Chem Co
What technology area does this patent fall under?
Primary CPC classification C07C69/96. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).